Report Detail

Request for Sample of this report

Pharma & Healthcare Global Orally Disintegrating Tablet (ODT) Market Growth 2018-2023

  • RnM2746770
    • |
  • 10 January, 2019
    • |
  • Global
    • |
  • 158 Pages
    • |
  • LPI(LP Information)
    • |
  • Pharma & Healthcare

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.

According to this study, over the next five years the Orally Disintegrating Tablet (ODT) market will register a CAGR in terms of revenue, the global market size will reach US$ million by 2023, from US$ million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Orally Disintegrating Tablet (ODT) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Orally Disintegrating Tablet (ODT) market by product type, application, key manufacturers and key regions and countries.

This study considers the Orally Disintegrating Tablet (ODT) value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7.
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 11.8.
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Orally Disintegrating Tablet (ODT) consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Orally Disintegrating Tablet (ODT) market by identifying its various subsegments.
Focuses on the key global Orally Disintegrating Tablet (ODT) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Orally Disintegrating Tablet (ODT) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Orally Disintegrating Tablet (ODT) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2018-2023 Global Orally Disintegrating Tablet (ODT) Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Orally Disintegrating Tablet (ODT) Consumption 2013-2023
        • 2.1.2 Orally Disintegrating Tablet (ODT) Consumption CAGR by Region
      • 2.2 Orally Disintegrating Tablet (ODT) Segment by Type
        • 2.2.1 Anti-Psychotics Drug
        • 2.2.2 Anti-Epileptics Drug
        • 2.2.3 Other
      • 2.3 Orally Disintegrating Tablet (ODT) Consumption by Type
        • 2.3.1 Global Orally Disintegrating Tablet (ODT) Consumption Market Share by Type (2013-2018)
        • 2.3.2 Global Orally Disintegrating Tablet (ODT) Revenue and Market Share by Type (2013-2018)
        • 2.3.3 Global Orally Disintegrating Tablet (ODT) Sale Price by Type (2013-2018)
      • 2.4 Orally Disintegrating Tablet (ODT) Segment by Application
        • 2.4.1 CNS Diseases
        • 2.4.2 Gastrointestinal Diseases
        • 2.4.3 CVS Diseases
        • 2.4.4 Other
      • 2.5 Orally Disintegrating Tablet (ODT) Consumption by Application
        • 2.5.1 Global Orally Disintegrating Tablet (ODT) Consumption Market Share by Application (2013-2018)
        • 2.5.2 Global Orally Disintegrating Tablet (ODT) Value and Market Share by Application (2013-2018)
        • 2.5.3 Global Orally Disintegrating Tablet (ODT) Sale Price by Application (2013-2018)

      3 Global Orally Disintegrating Tablet (ODT) by Players

      • 3.1 Global Orally Disintegrating Tablet (ODT) Sales Market Share by Players
        • 3.1.1 Global Orally Disintegrating Tablet (ODT) Sales by Players (2016-2018)
        • 3.1.2 Global Orally Disintegrating Tablet (ODT) Sales Market Share by Players (2016-2018)
      • 3.2 Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Players
        • 3.2.1 Global Orally Disintegrating Tablet (ODT) Revenue by Players (2016-2018)
        • 3.2.2 Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Players (2016-2018)
      • 3.3 Global Orally Disintegrating Tablet (ODT) Sale Price by Players
      • 3.4 Global Orally Disintegrating Tablet (ODT) Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Orally Disintegrating Tablet (ODT) Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Orally Disintegrating Tablet (ODT) Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Orally Disintegrating Tablet (ODT) by Regions

      • 4.1 Orally Disintegrating Tablet (ODT) by Regions
        • 4.1.1 Global Orally Disintegrating Tablet (ODT) Consumption by Regions
        • 4.1.2 Global Orally Disintegrating Tablet (ODT) Value by Regions
      • 4.2 Americas Orally Disintegrating Tablet (ODT) Consumption Growth
      • 4.3 APAC Orally Disintegrating Tablet (ODT) Consumption Growth
      • 4.4 Europe Orally Disintegrating Tablet (ODT) Consumption Growth
      • 4.5 Middle East & Africa Orally Disintegrating Tablet (ODT) Consumption Growth

      5 Americas

      • 5.1 Americas Orally Disintegrating Tablet (ODT) Consumption by Countries
        • 5.1.1 Americas Orally Disintegrating Tablet (ODT) Consumption by Countries (2013-2018)
        • 5.1.2 Americas Orally Disintegrating Tablet (ODT) Value by Countries (2013-2018)
      • 5.2 Americas Orally Disintegrating Tablet (ODT) Consumption by Type
      • 5.3 Americas Orally Disintegrating Tablet (ODT) Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Orally Disintegrating Tablet (ODT) Consumption by Countries
        • 6.1.1 APAC Orally Disintegrating Tablet (ODT) Consumption by Countries (2013-2018)
        • 6.1.2 APAC Orally Disintegrating Tablet (ODT) Value by Countries (2013-2018)
      • 6.2 APAC Orally Disintegrating Tablet (ODT) Consumption by Type
      • 6.3 APAC Orally Disintegrating Tablet (ODT) Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Orally Disintegrating Tablet (ODT) by Countries
        • 7.1.1 Europe Orally Disintegrating Tablet (ODT) Consumption by Countries (2013-2018)
        • 7.1.2 Europe Orally Disintegrating Tablet (ODT) Value by Countries (2013-2018)
      • 7.2 Europe Orally Disintegrating Tablet (ODT) Consumption by Type
      • 7.3 Europe Orally Disintegrating Tablet (ODT) Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Orally Disintegrating Tablet (ODT) by Countries
        • 8.1.1 Middle East & Africa Orally Disintegrating Tablet (ODT) Consumption by Countries (2013-2018)
        • 8.1.2 Middle East & Africa Orally Disintegrating Tablet (ODT) Value by Countries (2013-2018)
      • 8.2 Middle East & Africa Orally Disintegrating Tablet (ODT) Consumption by Type
      • 8.3 Middle East & Africa Orally Disintegrating Tablet (ODT) Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.2 Orally Disintegrating Tablet (ODT) Distributors
      • 10.3 Orally Disintegrating Tablet (ODT) Customer

      11 Global Orally Disintegrating Tablet (ODT) Market Forecast

      • 11.1 Global Orally Disintegrating Tablet (ODT) Consumption Forecast (2018-2023)
      • 11.2 Global Orally Disintegrating Tablet (ODT) Forecast by Regions
        • 11.2.1 Global Orally Disintegrating Tablet (ODT) Forecast by Regions (2018-2023)
        • 11.2.2 Global Orally Disintegrating Tablet (ODT) Value Forecast by Regions (2018-2023)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Orally Disintegrating Tablet (ODT) Forecast by Type
      • 11.8 Global Orally Disintegrating Tablet (ODT) Forecast by Application

      12 Key Players Analysis

      • 12.1 Teva
        • 12.1.1 Company Details
        • 12.1.2 Orally Disintegrating Tablet (ODT) Product Offered
        • 12.1.3 Teva Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.1.4 Main Business Overview
        • 12.1.5 Teva News
      • 12.2 Merck
        • 12.2.1 Company Details
        • 12.2.2 Orally Disintegrating Tablet (ODT) Product Offered
        • 12.2.3 Merck Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.2.4 Main Business Overview
        • 12.2.5 Merck News
      • 12.3 Mylan
        • 12.3.1 Company Details
        • 12.3.2 Orally Disintegrating Tablet (ODT) Product Offered
        • 12.3.3 Mylan Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.3.4 Main Business Overview
        • 12.3.5 Mylan News
      • 12.4 Pfizer
        • 12.4.1 Company Details
        • 12.4.2 Orally Disintegrating Tablet (ODT) Product Offered
        • 12.4.3 Pfizer Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.4.4 Main Business Overview
        • 12.4.5 Pfizer News
      • 12.5 Johnson and Johnson
        • 12.5.1 Company Details
        • 12.5.2 Orally Disintegrating Tablet (ODT) Product Offered
        • 12.5.3 Johnson and Johnson Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.5.4 Main Business Overview
        • 12.5.5 Johnson and Johnson News
      • 12.6 GSK
        • 12.6.1 Company Details
        • 12.6.2 Orally Disintegrating Tablet (ODT) Product Offered
        • 12.6.3 GSK Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.6.4 Main Business Overview
        • 12.6.5 GSK News
      • 12.7 Otsuka
        • 12.7.1 Company Details
        • 12.7.2 Orally Disintegrating Tablet (ODT) Product Offered
        • 12.7.3 Otsuka Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.7.4 Main Business Overview
        • 12.7.5 Otsuka News
      • 12.8 Eli Lilly and Company
        • 12.8.1 Company Details
        • 12.8.2 Orally Disintegrating Tablet (ODT) Product Offered
        • 12.8.3 Eli Lilly and Company Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.8.4 Main Business Overview
        • 12.8.5 Eli Lilly and Company News
      • 12.9 AstraZeneca
        • 12.9.1 Company Details
        • 12.9.2 Orally Disintegrating Tablet (ODT) Product Offered
        • 12.9.3 AstraZeneca Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.9.4 Main Business Overview
        • 12.9.5 AstraZeneca News
      • 12.10 Bristol-Myers Squibb
        • 12.10.1 Company Details
        • 12.10.2 Orally Disintegrating Tablet (ODT) Product Offered
        • 12.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet (ODT) Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.10.4 Main Business Overview
        • 12.10.5 Bristol-Myers Squibb News
      • 12.11 Conquer

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Orally Disintegrating Tablet (ODT) . Industry analysis & Market Report on Orally Disintegrating Tablet (ODT) is a syndicated market report, published as Global Orally Disintegrating Tablet (ODT) Market Growth 2018-2023. It is complete Research Study and Industry Analysis of Orally Disintegrating Tablet (ODT) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,660.00
      		$5,490.00
      		$7,320.00
      		2,917.02
      		4,375.53
      		5,834.04
      		3,400.14
      		5,100.21
      		6,800.28
      		559,723.80
      		839,585.70
      		1,119,447.60
      		305,317.20
      		457,975.80
      		610,634.40
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo